US FDA clears cardiovascular surgery planning software
The US FDA has cleared a cardiovascular surgery planning software suite from Materialise (Leuven, Belgium) designed to provide support for transcatheter mitral valve replacements.
Please sign in or register for FREE
Sign in to 3DMedNet
Not a member yet? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Journal of 3D Printing in Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your 3DMedNet account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>